Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enovix Corporation (ENVX) vs GSK plc (GSK) Price & Performance

Enovix CorporationTrade
GSK plcTrade

Price performance (Past 24H)

Key statistics

Enovix Corporation vs GSK plc — how do they compare? Enovix Corporation trades at $4.84 (market cap $1.11B), while GSK plc trades at $52.34 (market cap $101.34B). The key difference: GSK plc is far larger — about 91.3× Enovix Corporation's market cap, and GSK plc pays a 3.49% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.

ENVXGSK
Market Cap
$1.11B$101.34B
Sector
TechnologyHealth
52-Week High
$15.93$61.18
52-Week Low
$4.84$36.20
Enterprise Value
$1.13B$121.95B
Dividend Yield
3.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enovix Corporation

No Aura AI signal available yet.

GSK plc

GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.

The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enovix Corporation

Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.

Read more on ENVX

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK